ATLANTA, June 11, 2021 / PRNewswire / – Invesco Ltd. (NYSE: IVZ), a leading global asset manager, today announced the launch of two new Exchange Traded Funds (ETFs) covering cutting edge technology topics – biotechnology and semiconductors. The new ETFs track the Nasdaq Biotechnology Index and the PHLX Semiconductor Sector Index. Maintained by Nasdaq, Inc. (Nasdaq), these indexes are the oldest benchmarks for each of the topics that have become more relevant with current events over the past year.
Through a partnership with the Nasdaq, Invesco waived until. on the consulting fees from IBBQ and SOXQ December 17, 2021, effectively bringing the total expense ratio of each ETF to 0 basis points, to December 17, 2021.
Starting today, the following new ETFs will be trading on the Nasdaq Stock Market:
– Invesco Nasdaq Biotechnology ETF (IBBQ)
– Invesco PHLX Semiconductor ETF (SOXQ)
“We are excited to expand our relationship with Nasdaq to provide investors with further access to innovative companies that are currently shaping the way we live and work,” said Anna Paglia, Global Head of ETFs & Indexed Strategies at Invesco. “There has never been a more relevant moment to these two topics, and we are delighted that we have now been able to offer investors the most cost-effective way to invest in Nasdaq-listed companies through indices that have been live for nearly three decades.”
Over the past year, advances in technology – where semiconductors are critical – have greatly impacted the way people engaged during the pandemic. The biotechnology room has paved the way for society out of the pandemic. The past year has underscored the importance of these companies, which are often well positioned to benefit from transformative technology issues as these companies continue to develop their critical role in society. Now Invesco is able to bring these strategies to market through two new ETFs that will be the most competitive products in their respective categories.
“The addition of these two ETFs strengthens our already robust offering in the technology sector and thematic industries within that sector,” said Paglia. “Invesco continues to expand its ETF offering to allow clients to choose the exposures that will help them get the best results.”
The Invesco Nasdaq Biotechnology ETF (IBBQ) provides broad and meaningful access to over 270 innovative biotechnology companies listed on the Nasdaq Stock Market. Its ingredients include a high concentration of companies that have been critical to Covid vaccines and treatments, as well as the continued growth of genomics, wellness, and advanced medical therapeutics. IBBQ is weighted according to market capitalization and includes large, mid and small cap companies in every growth phase. After this December 17, 2021, it will have a total expense ratio of 19 basis points, making it the most cost-effective approach to biotechnology.
The Invesco PHLX Semiconductor ETF (SOXQ) tracks an index that has tracked the 30 biggest names in semiconductor design and manufacture for nearly 30 years before smartphones hit the market and laptops became widespread. Although interest in semiconductors has evolved, the PHLX Semiconductor Sector Index continues to provide undiluted exposure to the semiconductor sector through a simple methodology that provides a simple definition of what constitutes a company included in the topic. As the demand for semiconductors has exceeded supply recently, there is potential for further growth in this area. After this December 17, 2021, SOXQ provides access to these companies at a cost-effective total expense ratio of 19 basis points, making SOXQ 16 basis points cheaper than the next cheapest ETF in this category.
“Nasdaq is proud to partner with a global community of leading healthcare and semiconductor companies,” said Lauren Dillard, Executive Vice President and Head of Investment Intelligence at Nasdaq. “We are excited to leverage our rules-based and transparent indices and look forward to building on our partnership with Invesco to offer investment products that enable investors to gain significant exposure to the breakthrough companies that will change tomorrow.”
About Invesco Ltd.
Invesco Ltd. (TickerNYSE: IVZ) is a global independent investment management company dedicated to delivering an investment experience that helps people get more with their lives. With offices in more than 20 countries, our distinctive investment teams offer a comprehensive range of active, passive and alternative investment opportunities. Invesco managed USA $ 1.4 trillion in assets on behalf of clients worldwide March 31, 2021. For more information visit www.invesco.com/corporate.
Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse range of data, analysis, software and services enable our customers to optimize and execute their business visions with confidence. To learn more about the company, technology solutions and career opportunities, visit us at LinkedIn, on twitter @Nasdaq, or at www.nasdaq.com.
No deposit | Not FDIC insured | Not guaranteed by the bank | May lose value | Not insured by any federal agency
A direct investment in an index is not possible.
This is not a recommendation of any investment strategy or product for any particular investor. Investors should consult a financial professional before making any investment decisions.
There are risks associated with investing in ETFs, including the possibility of losing money. Stocks are not actively managed and are subject to similar risks as stocks, including those related to short selling and margin maintenance obligations. The usual brokerage commissions apply. The fund’s return may not match the return of the underlying index. The Fund is subject to certain other risks. For more information on the risks associated with investing in the fund, please refer to the current prospectus.
Investments that focus on a specific industry, such as semiconductors and biotechnology, and sectors such as information technology and healthcare, are more at risk and more affected by market volatility than more diversified investments.
Small and medium-sized company stocks are generally more susceptible to adverse developments, can be more volatile, illiquid or restricted in terms of resale.
Invesco PHLX Semiconductor ETF and Invesco Nasdaq Biotechnology ETF are not sponsored, endorsed, sold or promoted by NASDAQ OMX Group, Inc. or its affiliates (NASDAQ OMX and its affiliates are referred to as the “Companies”). The companies assume no liability in connection with the administration, marketing or trading of the Invesco PHLX Semiconductor ETF or the Invesco Nasdaq Biotechnology ETF. “NASDAQ®” is a registered trademark and is used under license.
Shares are not individually redeemable and Shareholders can purchase these Shares from the Fund and offer these Shares to the Fund for redemption only in aggregations of Creation Units, which normally consist of 10,000 Shares.
Investors should read the prospectus / summary prospectus carefully before investing and carefully consider the investment objectives, risks, fees and expenses. This and other information about the Fund can be obtained by calling 800 983 0903 or visit invesco.com for the prospectus / summary prospectus.
Invesco Distributors, Inc. is the US distributor for Invesco’s retail products and private placements. It is an indirect wholly-owned subsidiary of Invesco Ltd.
Contact: Stephanie Diiorio, 212 278 9037 [email protected]
SOURCE Invesco Ltd.